SynthesisBMC endocrine disorders2026
Optimal time window of postprandial exercise in middle-aged and older adults with type 2 diabetes mellitus: a systematic review and meta-analysis.
Synthesis in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPostprandial hyperglycemia constitutes an independent risk factor for diabetic complications, particularly in middle-aged and older adults with type 2 diabetes mellitus (T2DM). Although exercise timing may critically modulate postprandial glycemic control, the optimal time window for this population remains to be established.
objectiveTo systematically evaluate the effect of postprandial exercise on glycemic control in middle-aged and older adults with type 2 diabetes mellitus (T2DM), and to provide evidence-based recommendations for optimal postprandial exercise timing.
methodsA systematic search of PubMed, Embase, Cochrane Library, and other databases was performed. Fourteen randomized crossover or parallel controlled trials involving 440 middle-aged and older patients with T2DM were included. The intervention was postprandial exercise. A random-effects meta-analysis was conducted, with subgroup analyses exploring the effects of exercise modality, timing, and disease duration on postprandial glucose area under the curve (AUC) and postprandial blood glucose levels.
resultsThis study found that, compared with the control group, postprandial exercise significantly reduced both the glucose AUC (8 studies, 11 effect sizes; Hedges' g = - 0.61; SE = 0.16; P < 0.05) and postprandial blood glucose levels (6 studies, 12 effect sizes; Hedges' g = - 1.82; SE = 0.23; P < 0.05). Postprandial exercise contributed to improved acute glycemic control in middle-aged and older adults with T2DM. Notably, the non-aerobic-only exercise subgroup (e.g., passive stretching, resistance exercise, or combined exercise) demonstrated a more pronounced effect in reducing postprandial glucose AUC in this population. Although no statistically significant differences were observed across postprandial exercise timing subgroups for either glycemic outcome, the 30-90 min postprandial subgroup showed a numerically larger reduction in postprandial blood glucose effect sizes.
conclusionPostprandial exercise can reduce postprandial blood glucose levels and the postprandial glucose AUC in middle-aged and older patients with type 2 diabetes. Non-aerobic-only exercise (e.g., passive stretching, resistance exercise, or combined exercise) appears to be more suitable for glycemic control in this population, although this finding remains preliminary. Initiating exercise within the 30-90 min postprandial window may be more effective in improving postprandial blood glucose. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.